ScoreWhy is Adaptive Biotechnologies Corp. ?
1
With a growth in Operating Profit of 91.28%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 8 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD -27.04 MM
- NET SALES(HY) At USD 142.56 MM has Grown at 42.69%
- NET PROFIT(HY) Higher at USD -32.62 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 67.34%, its profits have risen by 60.7%
3
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating performance in long term as well as near term
- Along with generating 67.34% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Adaptive Biotechnologies Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Adaptive Biotechnologies Corp. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Adaptive Biotechnologies Corp.
67.34%
5.73
69.46%
S&P 500
25.22%
1.91
13.23%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
23.00%
EBIT Growth (5y)
10.21%
EBIT to Interest (avg)
-88.31
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.53
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.73
EV to EBIT
-31.93
EV to EBITDA
-46.43
EV to Capital Employed
13.82
EV to Sales
6.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-43.29%
ROE (Latest)
-27.18%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend21What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -27.04 MM
NET SALES(HY)
At USD 142.56 MM has Grown at 42.69%
NET PROFIT(HY)
Higher at USD -32.62 MM
ROCE(HY)
Highest at -24.43%
RAW MATERIAL COST(Y)
Fallen by -14.67% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 8.42 times
DEBTORS TURNOVER RATIO(HY)
Highest at 6.22 times
-2What is not working for the Company
PRE-TAX PROFIT(Q)
At USD -19.03 MM has Fallen at -27.99%
NET PROFIT(Q)
At USD -19.04 MM has Fallen at -28.02%
Here's what is working for Adaptive Biotechnologies Corp.
Operating Cash Flow
Highest at USD -27.04 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
At USD 142.56 MM has Grown at 42.69%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Inventory Turnover Ratio
Highest at 8.42 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 6.22 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -14.67% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Adaptive Biotechnologies Corp.
Pre-Tax Profit
At USD -19.03 MM has Fallen at -27.99%
over average net sales of the previous four periods of USD -14.86 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -19.04 MM has Fallen at -28.02%
over average net sales of the previous four periods of USD -14.87 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
